These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32557704)

  • 1. Impact of PNPLA3 (rs738409-G) polymorphism on post-transplant outcomes after liver transplantation for alcohol-related liver disease.
    Yoo T; Lee KW; Yi NJ; Hong SK; Lee JM; Kim H; Lim J; Seo S; Suh KS
    Clin Transplant; 2020 Sep; 34(9):e14011. PubMed ID: 32557704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
    Finkenstedt A; Auer C; Glodny B; Posch U; Steitzer H; Lanzer G; Pratschke J; Biebl M; Steurer M; Graziadei I; Vogel W; Zoller H
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1667-72. PubMed ID: 23872669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.
    Zhang Y; Guo T; Yang F; Mao Y; Li L; Liu C; Sun Q; Li Y; Huang J
    Hepatol Int; 2018 Sep; 12(5):429-437. PubMed ID: 30132178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNPLA3 Association with Alcoholic Liver Disease in a Cohort of Heavy Drinkers.
    Kolla BP; Schneekloth TD; Biernacka J; Shah V; Lazaridis KN; Geske J; Karpyak V
    Alcohol Alcohol; 2018 Jul; 53(4):357-360. PubMed ID: 29474507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population.
    Peregud DI; Baronets VY; Lobacheva AS; Ivanov AS; Arisheva OS; Garmash IV; Kobalava ZD; Pirozhkov SV; Terebilina NN
    Ann Hepatol; 2021; 20():100247. PubMed ID: 32871288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study.
    Trunečka P; Míková I; Dlouhá D; Hubáček JA; Honsová E; Kolesár L; Lánská V; Fraňková S; Šperl J; Jirsa M; Poledne R
    Dig Liver Dis; 2018 May; 50(5):490-495. PubMed ID: 29396131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.
    Sedki M; Kwong A; Bhargava M; Ahmed A; Daugherty T; Kwo P; Dronamraju D; Kumari R; Kim WR; Esquivel C; Melcher M; Bonham CA; Gallo A; Nelson A; Norwood A; Hussain F; Goel A
    Transplantation; 2024 Mar; 108(3):742-749. PubMed ID: 37899485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PNPLA3 I148M polymorphism on histologically proven non-alcoholic fatty liver disease in liver transplant recipients.
    Kim H; Lee KW; Lee K; Seo S; Park MY; Ahn SW; Hong SK; Yoon KC; Kim HS; Choi Y; Lee HW; Yi NJ; Suh KS
    Hepatol Res; 2018 Feb; 48(3):E162-E171. PubMed ID: 28718984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Alcohol Relapse Among Liver Transplant Candidates With Less Than 6 Months of Abstinence Using the High-Risk Alcoholism Relapse Score.
    Lombardo-Quezada J; Colmenero J; López-Pelayo H; Gavotti C; Lopez A; Crespo G; Lopez E; Gual A; Lligoña A; Navasa M
    Liver Transpl; 2019 Aug; 25(8):1142-1154. PubMed ID: 30920118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.
    Salameh H; Raff E; Erwin A; Seth D; Nischalke HD; Falleti E; Burza MA; Leathert J; Romeo S; Molinaro A; Corradini SG; Toniutto P; Spengler U; Daly A; Day CP; Kuo YF; Singal AK
    Am J Gastroenterol; 2015 Jun; 110(6):846-56. PubMed ID: 25964223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
    Senkerikova R; Frankova S; Jirsa M; Kreidlova M; Merta D; Neroldova M; Chmelova K; Spicak J; Sperl J
    PLoS One; 2019; 14(9):e0222609. PubMed ID: 31527889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
    Atkinson SR; Way MJ; McQuillin A; Morgan MY; Thursz MR
    J Hepatol; 2017 Jul; 67(1):120-127. PubMed ID: 28161471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C.
    Dunn W; O'Neil M; Zhao J; Wu CH; Roberts B; Chakraborty S; Sherman C; Weaver B; Taylor R; Olson J; Olyaee M; Gilroy R; Schmitt T; Wan YJ; Weinman SA
    Hepatology; 2014 Feb; 59(2):453-60. PubMed ID: 24123231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant Outcomes of Persons Receiving a Liver Graft for Alcoholic Liver Disease.
    Rogal S; Shenai N; Kruckenberg K; Rosenberger E; Dew MA; DiMartini A
    Alcohol Alcohol; 2018 Mar; 53(2):157-165. PubMed ID: 29293880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good outcome after liver transplantation for ALD without a 6 months abstinence rule prior to transplantation including post-transplant CDT monitoring for alcohol relapse assessment - a retrospective study.
    Kollmann D; Rasoul-Rockenschaub S; Steiner I; Freundorfer E; Györi GP; Silberhumer G; Soliman T; Berlakovich GA
    Transpl Int; 2016 May; 29(5):559-67. PubMed ID: 26865285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation.
    Míková I; Neřoldová M; Hubáček JA; Dlouhá D; Jirsa M; Honsová E; Sticová E; Lánská V; Špičák J; Trunečka P
    Transplantation; 2020 Mar; 104(3):526-534. PubMed ID: 31356578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival and predictors of relapse and survival after liver transplantation for alcoholic liver disease.
    Lindenger C; Castedal M; Schult A; Åberg F
    Scand J Gastroenterol; 2018 Dec; 53(12):1553-1561. PubMed ID: 30678557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.